Validity and reliability of the Portuguese version of the Epilepsy Medication Treatment Complexity Index for Brazil

Epilepsy and Behavior

Volumn 21, Issue 4, 2011, Pages 467-472

  Ferrari, Carla Maria Maluf ^a,b   Castro, Luiz Henrique Martins ^a   Settervall, Cristina Helena Costanti ^a   de Moura, Rosimary Maria ^a   Coutinho, Pollyana Aurichio ^b   Oshiro, Iolanda Eiko Shirota ^b   Alves, Roseane Batista ^b   de Sousa, Regina Marcia Cardoso ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Centro Universitario Sao Camilo   (Brazil)

Author keywords

Ambulatory care; Complexity; Epilepsy; Treatment

Indexed keywords

ANTICONVULSIVE AGENT;

ADULT; ARTICLE; BRAZIL; CLINICAL ARTICLE; COGNITIVE DEFECT; CONSTRUCT VALIDITY; CORRELATION COEFFICIENT; DAILY LIFE ACTIVITY; EPILEPSY; EPILEPSY MEDICATION TREATMENT COMPLEXITY INDEX; FEMALE; FOCAL EPILEPSY; HUMAN; INTERRATER RELIABILITY; MALE; MORISKY SCALE; PERCEPTION; PSYCHOMETRY; RATING SCALE; SCORING SYSTEM; SEIZURE; TEMPORAL LOBE EPILEPSY;

ADOLESCENT; ADULT; ANTICONVULSANTS; BRAZIL; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 80051472161     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2011.04.054     Document Type: Article

References (39)

1. Jones R.M., Butler J.A., Thomas V.A., et al. Adherence to treatment in patients with epilepsy: associations with seizure control and illness beliefs. Seizure 2006, 15:504-508.
2. McCorry D., Chadwick D., Marson A. Current drug treatment of epilepsy in adults. Lancet Neurol 2004, 3:729-735.
3. Ben-Menachem E., Sander J.W., Privitera M., et al. Measuring outcomes of treatment with antiepileptic drugs in clinical trials. Epilepsy Behav 2010, 18:24-30.
4. Yeager K.A., DiIorio C., Shafer P.O., et al. The complexity of treatments for persons with epilepsy. Epilepsy Behav 2005, 7:679-686.
5. DiIorio C., Yeager K.A., Shafer P.O., et al. The epilepsy medication and treatment complexity index: reliability and validity testing. J Neurosci Nurs 2003, 35:155-162.
6. Handoko K.B., Zwart-van Rijkom, Visee H.F., et al. Drug treatment-related factors of inadequate seizure control. Epilepsy Behav 2008, 13:545-548.
7. Cramer J.A., Glassman M., Rienzi V. The relationship between poor medication compliance and seizures. Epilepsy Behav 2002, 3:338-342.
8. Hovinga A.C., Asato M.R., Manjunath R., et al. Association of non-adherence to antiepileptic drugs and seizures, quality of life, and productivity: survey of patients with epilepsy and physicians. Epilepsy Behav 2008, 13:316-322.
9. Beaton D.E., Bombardier C., Guilleman F., Ferraz M.B. Guidelines for the process of cross-cultural adaptation of self-report measures. SPINE 2000, 25:3186-3191.
10. Commission on Classification and Terminology of the International League Against Epilepsy Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989, 30:389-399.
11. Callegari Jacques S.M. Bioestatística princípios e aplicações 2003, 84-93. Artmed, Porto Alegre.
12. Morisky D.E., Green L.W., Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986, 24:67-74.
13. Anderson T.W., Darling D.A. Asymptotic theory of certain "goodness-of-fit" criteria based on stochastic process. Ann Stat 1952, 23:193-212.
14. Vieira S. Análise de variância: ANOVA 2006, 80-88. Atlas, São Paulo.
15. Pennell P.B., Thompson P. Gender-specific psychosocial impact of living with epilepsy. Epilepsy Behav 2009, 15(Suppl. 1):S20-S25.
16. Kobau R., DiIorio C.A., Anderson L.A. Further validation and reliability testing of the Attitudes and Beliefs about Living with Epilepsy (ABLE) components of the CDC Epilepsy Program Instrument on Stigma. Epilepsy Behav 2006, 8:552-559.
17. Kobau R., DiIorio C.A., Price P.H., et al. Prevalence of epilepsy and health status of adults with epilepsy in Georgia and Tennessee: Behavioral Risk Factor Surveillance System. Epilepsy Behav 2004, 5:358-366.
18. Sarmento M.R.S., Minayo Ges C. A epilepsia, o epiléptico e o trabalho: relações conflitantes. Cad Saude Publica 2000, 16:183-193.
19. Jae-Kook Y., Ki-Young J., Kun-Woo P., et al. Familiarity with, understanding of, and attitudes toward epilepsy among people with epilepsy and healthy controls in South Korea. Epilepsy Behav 2009, 16:260-267.
20. Mantoan M.A.S., Caboclo L.O.S.F., Guilhoto L.M.F.F., et al. Correlation between memory, proton magnetic resonance spectroscopy, and interictal epileptiform discharges in temporal lobe epilepsy related to mesial temporal sclerosis. Epilepsy Behav 2009, 16:447-453.
21. Andrade-Valença L.P.A., Valença M.M., Velasco T.R., Leite J.P. Epilepsia do lobo temporal mesial associada à esclerose hipocampal. J Epilepsy Clin Neurophysiol 2006, 12:31-36.
22. Wheless J.W. Intractable epilepsy: a survey of patients and caregivers. Epilepsy Behav 2006, 8:756-764.
23. McAuley J.W., McFadden L.S., Elliot J.O., Shneker B.F. An evaluation of self-management behaviors and medication adherence in patients with epilepsy. Epilepsy Behav 2008, 13:637-641.
24. Martins H.H., Alonso N.B., Guilhoto L.M.F.F., Guaranha M.S.B., Yacubian E.M.T. Adherence to treatment in patients with juvenile myoclonic epilepsy: correlation with quality of life and adverse effects of medication. J Epilepsy Clin Neurophysiol 2009, 15:192-196.
25. Dewulf N.L.F., Monteiro R.A., Passos A.D.C., Vieira E.M., Troncon L.E.A. Adesão ao tratamento medicamentoso em doenças gastrintestinais crônicas acompanhados no ambulatório de um hospital universitário. Rev Bras Cienc Farm 2006, 42:575-584.
26. Marques P.A.C., Pierin A.M.G. Fatores que influenciam a adesão de pacientes com câncer à terapia antineoplásica oral. Acta Paul Enferm 2008, 21:323-329.
27. Santa Helena E.T., Nemes M.I.B., Eluf-Neto J. Development and validation of a multidimensional questionnaire assessing non-adherence to medicines. Rev Saúde Pública 2008, 42(4).
28. Strelec M.A.A.M., Pierin A.M.G., Mion D. A influência so conhecimento sobre a doença e a atitude frente a tomada dos remédios no controle da hipertensão arterial. Arq Bras Cardiol 2003, 81:343-348.
29. Medeiros ARC.Adesão ao tratamento anti-hipertensivo em unidade de saúde da família de João Pessoa-PB [dissertação]. João Pessoa: Centro de Ciências da Saúde, Universidade Federal da Paraíba; 2006.
30. Cornélio R.C.A.C., Pinto A.L.T., Pace F.H.L., Moraes J.P., Chebli J.M.F. Não adesão ao tratamento em pacientes com doença de Chron: prevalência e fatores de risco. Arq Gastroenterol 2009, 46:183-190.
31. Araújo M.F.M., Gonçalves T.C., Damasceno M.M.C., Caetano J.A. Aderência de diabéticos ao tratamento medicamentoso com hipoglicemiantes orais. Esc Anna Nery Rev Enferm 2010, 14:361-367.
32. Melchiors A.C., Correr C.J., Fernández-Llimoset F. Tradução e validação para o português do medication regimen complexity índex. Arq Bras Cardiol 2007, 89:210-218.
33. Elger C.E., Schmidt D. Modern management of epilepsy: a practical approach. Epilepsy Behav 2008, 12:501-539.
34. Hinkin C.H., Castellon S.A., Durvasula R.S., et al. Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology 2002, 59(12):1944-1950.
35. Rubin R.R. Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. Am J Med 2005, 118(Suppl. 5A):27-34S.
36. Richardson S.P., Farias S.T., Lima A.R., Alsaadi T.M. Improvement in seizure control and quality of life in medically refractory epilepsy patients converted from polypharmacy to monotherapy. Epilepsy Behav 2004, 5:343-347.
37. Ettinger A.B., Baker G.A. Best clinical and research practice in epilepsy of older people: focus on antiepileptic drug adherence. Epilepsy Behav 2009, 15(2, Suppl. 1):S60-S63.
38. Barbosa R.G.B., Costa L.N.K. Índices de adesão ao tratamento anti-hipertensivo no Brasil e mundo. Rev Bras Hipertens 2006, 13:35-38.
39. Figueiredo R.M., Sinkoo V.M., Tomazin C.C., Gallani M.C.B.J., Colombrini M.R.C. Adesão de pacientes com AIDS ao tratamento com antiretrovirais: dificuldades relatadas e proposição de medidas atenuantes em um hospital escola. Rev Lat Am Enfermagem 2001, 9:50-55.